Literature DB >> 8905447

Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily.

H J Gruss1.   

Abstract

The tumor necrosis factor receptor superfamily at present consists of ten different transmembrane (type I) glycoproteins with characteristic limited sequence homology for the cysteine-rich repeats in the extracellular domain. In parallel the tumor necrosis factor ligand super-family has been recognized by discovery of ligands for all members of the receptor superfamily. These molecules are also transmembrane (type II) glycoproteins, with the exception of lymphotoxin-alpha which is the only entirely secreted protein of the tumor necrosis factor-like proteins. Several members of the ligand superfamily, including tumor necrosis factor and CD95L also exist in a biologically active soluble form. The tumor necrosis factor ligand superfamily contains at present ten different proteins. In addition, NGFR p75 binds to a second family of proteins (neurotrophins). These nerve growth factor-like dimeric soluble molecules are basic neurotrophic factors and the five members (NGF, BDNF, NT-3, NT-4, NT-5) are not related to the tumor necrosis factor superfamily ligands. The members of the tumor necrosis factor ligand superfamily (TNF, LT-alpha, LT-beta, CD27L, CD30L, CD40L, CD95L, 4-IBB, OX40L, TRAIL) share common biological activities, but some properties are shared by only some ligands, while others are unique. The diverse biological activities triggered through tumor necrosis factor receptors have been linked to the regulation of cellular activation, including immune responses and inflammatory reactions, but also with the pathology of a series of human diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905447     DOI: 10.1007/bf02592977

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  16 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

Review 2.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

3.  Crystallization and preliminary X-ray crystallographic study of the extracellular domain of the 4-1BB ligand, a member of the TNF family.

Authors:  Jung-Sue Byun; Dong-Uk Kim; Byungchan Ahn; Byoung Se Kwon; Hyun-Soo Cho
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

4.  The co-evolution of our understanding of CD40 and inflammation.

Authors:  D H Wagner
Journal:  Diabetologia       Date:  2009-04-10       Impact factor: 10.122

5.  Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.

Authors:  A Wellmer; J Gerber; J Ragheb; G Zysk; T Kunst; A Smirnov; W Brück; R Nau
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Developmental Programming: Gestational Exposure to Excess Testosterone Alters Expression of Ovarian Matrix Metalloproteases and Their Target Proteins.

Authors:  Muraly Puttabyatappa; Ashleigh Irwin; Jacob D Martin; Makeda Mesquitta; Almudena Veiga-Lopez; Vasantha Padmanabhan
Journal:  Reprod Sci       Date:  2017-03-16       Impact factor: 3.060

7.  Minimal immunological effects on workers with prolonged low exposure to inorganic mercury.

Authors:  L Soleo; A Vacca; L Vimercati; S Bruno; M Di Loreto; C Zocchetti; R Di Stefano; G Candilio; G Lasorsa; G Franco; V Foa
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

8.  Comparison of nerve growth factor receptor binding models using heterodimeric muteins.

Authors:  Hrishikesh M Mehta; Sang B Woo; Kenneth E Neet
Journal:  J Neurosci Res       Date:  2012-08-18       Impact factor: 4.164

Review 9.  Epithelial cells as immune effector cells: the role of CD40.

Authors:  Kari Dugger; Thomas W Lowder; Torry A Tucker; Lisa M Schwiebert
Journal:  Semin Immunol       Date:  2009-07-22       Impact factor: 11.130

10.  Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.

Authors:  Jeongwu Lee; Monika Hampl; Paul Albert; Howard A Fine
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.